Impact of the US Food and Drug Administration’s safety-related announcements on the use of bisphosphonates after hip fracture

The U.S. FDA issued several announcements related to potential risk of bisphosphonates including osteonecrosis of the jaw (2005), atrial fibrillation (2007) and atypical femur fracture (2010). We aimed to evaluate the impact of three FDA drug safety announcements on the use of bisphosphonates in pat...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Bone Miner Res
Prif Awduron: Kim, Seoyoung C., Kim, Dae Hyun, Mogun, Helen, Eddings, Wesley, Polinski, Jennifer M., Franklin, Jessica M., Solomon, Daniel H
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5040596/
https://ncbi.nlm.nih.gov/pubmed/26969902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2832
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg